Non-GAAP net income per share is expected to be in the range of RMB8.25 to RMB8.37 on a fully diluted basis, assuming an estimated diluted share count of 114 million.
The company estimates its total share-based compensation expenses in 2008 will be approximately RMB70 million based on the employee share options that have been granted as of March 4, 2008. Total expense and/or amortization of intangible assets related to the April 2006 acquisition of minority interest will be approximately RMB18.8 million in 2008.
The company expects its capital expenditure for 2008 to be in the range of RMB700 million to RMB800 million.
The company's practice is to provide guidance on a full year basis only. This forecast reflects Mindray's current and preliminary views, which are subject to change.
Conference Call Information
Mindray's management will hold an earnings conference call at 8:00 PM
on March 5, 2008 U.S. Eastern Time (9:00 AM on March 6, 2008 Beijing/Hong
Dial-in details for the earnings conference call are as follows:
Hong Kong: +852-3002-1672
US Toll Free: +1-800-299-9086
Passcode for all regions: Mindray
A replay of the conference call may be accessed by phone at the
following numbers until March 16, 2008.
US Toll Free: +1-888-286-8010
Additionally, a live and archived webcast of this conference call will be available on the Investor Relations section of Mindray's website at http://www.mindray.com .
Mindray Medical International Limited is a leading developer,
manufacturer and marketer of medical devices in China with a significant
and growing presence worldwide. Established in 1991, Mindray offers a broad
range of products across
|SOURCE Mindray Medical International Limited|
Copyright©2008 PR Newswire.
All rights reserved